Basic Information
| ID | DRAMP21462 |
|---|
| Sequence | IHKFWRGGRWFKHI |
|---|
| Length | 14 |
|---|
| Name | GG (De Novo Synthesis) |
|---|
| Source | synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram- |
|---|
| Pathogen | [Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=16μM), Staphylococcus aureus ATCC 43300(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Streptococci faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=16μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 7731(MIC=64μM), Salmonella Pulloru C79-13(MIC=8μM) |
|---|
| Hemolytic Activity | [Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis. |
|---|
| Cytotoxicity | [Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by GG is 67.7%, 74.2%, 76.5%, 72.4%, 72.8%, 69.1%, 65.9% and 59.9% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Amidation |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 30538681 |
|---|
